Nuveen Asset Management, LLC Precision Biosciences Inc Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.15 - $3.34 $586,854 - $1.7 Million
-510,308 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.96 - $7.76 $104,712 - $274,517
35,376 Added 7.45%
510,308 $1.56 Million
Q4 2021

Feb 14, 2022
BUY
$7.4 - $11.66 $107,174 - $168,871
14,483 Added 3.15%
474,932 $3.52 Million
Q3 2021

Nov 12, 2021
BUY
$9.18 - $14.15 $2.72 Million - $4.19 Million
295,945 Added 179.9%
460,449 $5.31 Million
Q2 2021

Aug 16, 2021
SELL
$8.07 - $12.52 $86,034 - $133,475
-10,661 Reduced 6.09%
164,504 $2.06 Million
Q1 2021

May 17, 2021
BUY
$8.57 - $15.79 $187,717 - $345,864
21,904 Added 14.29%
175,165 $1.81 Million
Q4 2020

Feb 16, 2021
SELL
$5.98 - $12.47 $309,859 - $646,145
-51,816 Reduced 25.27%
153,261 $1.28 Million
Q3 2020

Nov 16, 2020
BUY
$4.65 - $8.73 $3,873 - $7,272
833 Added 0.41%
205,077 $1.26 Million
Q2 2020

Aug 14, 2020
BUY
$4.66 - $8.7 $88,502 - $165,230
18,992 Added 10.25%
204,244 $1.7 Million
Q1 2020

May 14, 2020
BUY
$5.05 - $15.01 $185,117 - $550,221
36,657 Added 24.67%
185,252 $1.12 Million
Q4 2019

Feb 14, 2020
BUY
$6.32 - $19.66 $853,269 - $2.65 Million
135,011 Added 993.9%
148,595 $2.06 Million
Q2 2019

Aug 15, 2019
BUY
$11.88 - $16.94 $161,377 - $230,112
13,584 New
13,584 $180,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $499M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email